한글목차

임상 검사 서비스 시장 규모는 2025년 2,420억 7,000만 달러에서 2026년부터 2034년까지 CAGR 4.45%로 성장하여 2034년에는 3,581억 9,000만 달러에 달할 것으로 예측됩니다.

임상 검사 서비스 시장은 진단 검사 수요 증가와 만성질환 유병률 상승을 배경으로 큰 폭의 성장이 예상됩니다. 임상 검사실은 질병의 발견, 경과 관찰, 관리를 지원하는 중요한 검사 서비스를 제공함으로써 의료에서 매우 중요한 역할을 담당하고 있습니다. 전 세계 고령화, 당뇨병, 심혈관질환, 감염성 질환 등의 질병 발생률이 높아짐에 따라 임상 검사 서비스 수요는 증가할 것으로 예상되며, 이 시장은 견조한 성장이 예상됩니다. 본 시장은 혈액검사, 병리, 미생물학, 분자진단 등 다양한 서비스를 포함하고 있습니다.

또한, 검사 기술의 발전은 임상 검사 서비스 시장의 혁신을 주도하고 있습니다. 현장 검사, 자동화, 첨단 진단 기술의 개발로 검사 서비스의 속도, 정확성, 효율성이 향상되고 있습니다. 이러한 혁신은 적시에 진단을 가능하게 하여 환자의 치료 결과를 개선할 뿐만 아니라, 검사 업무를 효율화하고 검사 결과 처리 시간을 단축할 수 있습니다. 새로운 검사 방법과 응용 분야에 대한 조사가 계속되는 가운데, 진단 능력과 환자 치료의 향상 가능성에 힘입어 임상 검사 서비스 시장은 더욱 확대될 것으로 예상됩니다.

또한, 예방의료와 맞춤의료에 대한 관심이 높아지면서 임상 검사 서비스 구조를 형성하고 있습니다. 의료 서비스 제공자들이 조기 발견과 개별화된 치료 접근법에 집중함에 따라, 개별 환자 프로필에 대한 정보를 제공하는 고급 진단 검사에 대한 수요가 증가할 것으로 예상됩니다. 이러한 추세는 환자의 고유한 유전자 구성을 이해하는 것이 치료 방침에 큰 영향을 미치는 유전체 분석 및 바이오마커 검사 분야에서 특히 중요합니다. 임상 검사 서비스 시장이 계속 진화하는 가운데, 기술 발전, 예방 의료에 대한 인식 제고, 맞춤형 의료에 대한 집중이 결합되어 향후 궤도를 형성하는 데 매우 중요한 역할을 할 것입니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 임상 검사 서비스 시장 : 테스트 유형별

제5장 세계의 임상 검사 서비스 시장 : 서비스 프로바이더별

제6장 세계의 임상 검사 서비스 시장 : 용도별

제7장 세계의 임상 검사 서비스 시장 : 지역별

제8장 경쟁 구도

제9장 기업 개요

영문목차

The Clinical Laboratory Services Market size is expected to reach USD 358.19 Billion in 2034 from USD 242.07 Billion (2025) growing at a CAGR of 4.45% during 2026-2034.

The clinical laboratory services market is poised for significant growth, driven by the increasing demand for diagnostic testing and the rising prevalence of chronic diseases. Clinical laboratories play a crucial role in healthcare by providing essential testing services that aid in disease detection, monitoring, and management. As the global population ages and the incidence of conditions such as diabetes, cardiovascular diseases, and infectious diseases rises, the demand for clinical laboratory services is expected to increase, positioning this market for robust expansion. The market encompasses a wide range of services, including blood tests, pathology, microbiology, and molecular diagnostics.

Moreover, advancements in laboratory technologies are propelling innovation within the clinical laboratory services market. The development of point-of-care testing, automation, and advanced diagnostic techniques is enhancing the speed, accuracy, and efficiency of laboratory services. These innovations not only improve patient outcomes by enabling timely diagnosis but also streamline laboratory operations, reducing turnaround times for test results. As research continues to explore new testing methodologies and applications, the clinical laboratory services market is likely to expand further, driven by the promise of improved diagnostic capabilities and patient care.

Additionally, the growing emphasis on preventive healthcare and personalized medicine is shaping the clinical laboratory services landscape. As healthcare providers increasingly focus on early detection and tailored treatment approaches, the demand for advanced diagnostic tests that provide insights into individual patient profiles is likely to rise. This trend is particularly relevant in the context of genomics and biomarker testing, where understanding a patient's unique genetic makeup can significantly impact treatment decisions. As the clinical laboratory services market continues to evolve, the combination of technological advancements, increased awareness of preventive care, and a focus on personalized medicine will play a crucial role in shaping its future trajectory.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

• Genetic Testing
• Clinical Chemistry
• Medical Microbiology Testing
• Hematology Testing
• Immunology Testing
• Cytology Testing
• Drug of Abuse Testing
• Others

By Service Provider

• Hospital-based Laboratories
• Stand-alone Laboratories
• Clinic-based Laboratories

By Application

• Bioanalytical & Lab Chemistry Services
• Toxicology Testing Services
• Cell & Gene Therapy Related Services
• Preclinical & Clinical Trial Related Services
• Drug Discovery & Development Related Services
• Others

COMPANIES PROFILED

• Laboratory Corporation of America Holdings LabCorp, Qiagen NV, Eurofins Scientific SE, Quest Diagnostics Incorporated, OPKO Health Inc, Siemens Medical Solutions USA Inc, NeoGenomics Laboratories, Fresenius Medical Care, ARUP Laboratories, Sonic Healthcare, Charles River Laboratories International Inc, SYNLAB International GmbH, Mayo Clinic Laboratories, Unilabs

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CLINICAL LABORATORY SERVICES MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Type
• 4.2. Genetic Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Clinical Chemistry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Medical Microbiology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Hematology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Immunology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Cytology Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Drug of Abuse Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CLINICAL LABORATORY SERVICES MARKET: BY SERVICE PROVIDER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Service Provider
• 5.2. Hospital-based Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Stand-alone Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Clinic-based Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CLINICAL LABORATORY SERVICES MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Bioanalytical & Lab Chemistry Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Toxicology Testing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Cell & Gene Therapy Related Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Preclinical & Clinical Trial Related Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Drug Discovery & Development Related Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CLINICAL LABORATORY SERVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Test Type
  • 7.2.2 By Service Provider
  • 7.2.3 By Application
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Test Type
  • 7.3.2 By Service Provider
  • 7.3.3 By Application
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Test Type
  • 7.4.2 By Service Provider
  • 7.4.3 By Application
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Test Type
  • 7.5.2 By Service Provider
  • 7.5.3 By Application
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Test Type
  • 7.6.2 By Service Provider
  • 7.6.3 By Application
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CLINICAL LABORATORY SERVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Laboratory Corporation Of America Holdings (LabCorp)
  • 9.2.2 Qiagen NV
  • 9.2.3 Eurofins Scientific SE
  • 9.2.4 Quest Diagnostics Incorporated
  • 9.2.5 OPKO Health Inc
  • 9.2.6 Siemens Medical Solutions USA Inc
  • 9.2.7 NeoGenomics Laboratories
  • 9.2.8 Fresenius Medical Care
  • 9.2.9 ARUP Laboratories
  • 9.2.10 Sonic Healthcare
  • 9.2.11 Charles River Laboratories International Inc
  • 9.2.12 SYNLAB International GmbH
  • 9.2.13 Mayo Clinic Laboratories
  • 9.2.14 Unilabs